{"news_desk": "Business", "print_page": "7", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "J Michael Pearson returns as chief executive of Valeant Pharmaceuticals after two months of medical leave; says he will restore investor confidence in beleaguered company.", "type_of_material": "News", "word_count": "686", "lead_paragraph": "J. Michael Pearson is returning as chief executive after two months, but is giving up his role as chairman.", "pub_date": "2016-02-29T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Valeant Pharmaceuticals Chief Returns From Medical Leave", "print_headline": "<span data-tag=\"loosen__9\">Valeant Chief Returns After Medical Leave</span>"}, "snippet": "J. Michael Pearson is returning as chief executive after two months, but is giving up his role as chairman.", "multimedia": [{"height": 126, "url": "images/2016/02/29/business/29valeant-web/29valeant-web-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/02/29/business/29valeant-web/29valeant-web-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 395, "url": "images/2016/02/29/business/29valeant-web/29valeant-web-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "395", "xlarge": "images/2016/02/29/business/29valeant-web/29valeant-web-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/02/29/business/29valeant-web/29valeant-web-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/02/29/business/29valeant-web/29valeant-web-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/02/29/business/valeant-pharmaceuticals-j-michael-pearson-ceo.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Pearson, John Michael (1959- )", "name": "persons"}, {"rank": "3", "is_major": "N", "value": "Ingram, Robert A", "name": "persons"}, {"rank": "4", "is_major": "N", "value": "Schiller, Howard B", "name": "persons"}, {"rank": "5", "is_major": "N", "value": "Appointments and Executive Changes", "name": "subject"}], "blog": [], "_id": "56d39e2438f0d86ef22e17b7", "source": "The New York Times"}